Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Ipsen receives CHMP recommendation for Cabometyx in combination with Opdivo

March 1, 2021 Sales and Marketing Cancer, EMA, ipsen

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for Ipsen’s Cabometyx (cabozantinib) in combination with …
News
cov

MAPs during a global pandemic

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
Feature

How COVID-19 has changed pharmacovigilance

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
Feature

GSK and Sanofi to begin new Phase II trial of their COVID-19 vaccine

February 22, 2021 Sales and Marketing COVID, COVID Vaccine, COVID-19, GSK, Sanofi

GlaxoSmithKline (GSK) and Sanofi are set to begin a new Phase II study of their COVID-19 vaccine candidate, following setbacks …
News

ONK and Anthony Nolan combine forces to work on blood cancer therapies

February 22, 2021 Sales and Marketing Anthony Nolan, Cancer, ONK, blood cancer, cancer treatment

ONK Therapeutics and blood cancer charity Anthony Nolan will work together on therapies for patients with haematological malignancies (blood cancers) …
News
minaris-mg_7425-web

MaxiVAX and Minaris sign manufacturing deal for cell-based cancer immunotherapy

February 22, 2021 Sales and Marketing Cancer, MaxiVAX, Minaris

MaxiVAX and Minaris Regenerative Medicine have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of …
News
astrazeneca_plaque

AstraZeneca to withdraw Imfinzi US indication for bladder cancer

February 22, 2021 Sales and Marketing AstraZeneca, Imfinzi

AstraZeneca will voluntarily withdraw the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or …
News
tukysa

Seagen’s breast cancer drug TUKYSA gets UK approval

February 22, 2021 Sales and Marketing Cancer, MHRA, Seagen

The MHRA has granted marketing authorisation in the UK for Seagen’s TUKYSA (tucatinib) in combination with trastuzumab and capecitabine, for …
News
Eli Lilly front sign

University of Glasgow and Lilly sign £4.6m immunological disease partnership

February 15, 2021 Sales and Marketing Eli Lilly, University of Glasgow, arthritis, fibrosis, lilly, uofg

The University of Glasgow and Eli Lilly and Company have entered into a research collaboration, across four diseases, worth £4.6 …
News

Pfizer COVID-19 vaccine proven 94% effective in biggest study yet

February 15, 2021 Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus

The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …
News
astrazeneca_sign_sky

AstraZeneca’s COVID-19 vaccine to be trialled in children

February 15, 2021 Sales and Marketing AstraZeneca, COVID-19

The Oxford-AstraZeneca COVID-19 vaccine is to be tested on children in the UK in a new trial commencing this month. …
News

Genentech’s injectable eye medicine extends time between treatments for two conditions

February 15, 2021 Sales and Marketing Genentech

Genentech has announced detailed, positive results from four Phase III studies of its investigational bispecific antibody, faricimab, for the treatment …
News

Molecular Templates signs cancer deal with BMS worth up to $1.3bn

February 15, 2021 Sales and Marketing Bristol-Myers Squibb, bristol myers squibb

Molecular Templates and Bristol Myers Squibb have entered into a worldwide strategic research collaboration worth up to $1.3 billion, to …
News
elizabeth_crain

Exscientia appoints Moelis & Company COO Elizabeth Crain to Board of Directors

February 10, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.
Appointment
mr058666-web

Merck, Pfizer, and 4D pharma join forces for bladder cancer clinical trial

February 8, 2021 Sales and Marketing Cancer, Merck, Pfizer

A clinical trial collaboration between 4D pharma, Merck, and Pfizer to treat locally advanced or metastatic urothelial carcinoma (UC), also …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026